|
|
||||||||







* Department of Pharmacology, School of Dentistry, Kyung Hee University, Seoul, Korea;
Immunomodulation Research Center and Graduate Program in Immunology and Biomedicine, University of Ulsan, Ulsan, Korea; and
College of Medicine and Korea Bio-MAX Center, Seoul National University, Seoul, Korea;
Cross-linking of 4-1BB, a member of the TNFR family, increased tyrosine phosphorylation of TCR-signaling molecules such as CD3
, CD3
, Lck, the linker for activation of T cells, and SH2 domain-containing leukocyte phosphoprotein of 76 kDa (SLP-76). In addition, incubation of activated CD8+ T cells with p815 cells expressing 4-1BBL led to redistribution of the lipid raft domains and Lck, protein kinase C-
, SLP-76, and phospholipase C-
1 (PLC-
1) on the T cell membranes to the areas of contact with the p815 cells and recruitment of 4-1BB, TNFR-associated factor 2, and phospho-tyrosine proteins to the raft domains. 4-1BB ligation also caused translocation of TNFR-associated factor 2, protein kinase C-
, PLC-
1, and SLP-76 to detergent-insoluble compartments in the CD8+ T cells, and cross-linking of 4-1BB increased intracellular Ca2+ levels apparently by activating PLC-
1. The redistribution of lipid rafts and Lck, as well as translocation of PLC-
1, and degradation of I
B-
in response to 4-1BB were inhibited by disrupting the formation of lipid rafts with methyl-
-cyclodextrin. These findings demonstrate that 4-1BB is a T cell costimulatory receptor that activates TCR-signaling pathways in CD8+ T cells.
This article has been cited by other articles:
![]() |
S. M. Shin, Y. H. Kim, B. K. Choi, P. M. Kwon, H.-W. Lee, and B. S. Kwon 4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation J. Leukoc. Biol., June 1, 2007; 81(6): 1455 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zhang, R. E. Sadun, R. S. Arias, M. L. Flanagan, S. M. Sachsman, Y.-C. Nien, L. A. Khawli, P. Hu, and A. L. Epstein Targeted and Untargeted CD137L Fusion Proteins for the Immunotherapy of Experimental Solid Tumors Clin. Cancer Res., May 1, 2007; 13(9): 2758 - 2767. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |